I expect any deal will need an independent experts report as to value, will need to cover off on conflicts in relation to voting and some serious assessment of related party dealings. Will be very interesting to see if it goes a takeover route or sale of substantial part of business. Watching.
- Forums
- ASX - By Stock
- CHM
- Ann: Chimeric partnering with Cell Therapies Australia
CHM
chimeric therapeutics limited
Add to My Watchlist
12.5%
!
0.5¢

Ann: Chimeric partnering with Cell Therapies Australia, page-13
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.5¢ |
Change
0.001(12.5%) |
Mkt cap ! $9.068M |
Open | High | Low | Value | Volume |
0.4¢ | 0.5¢ | 0.4¢ | $3.336K | 821.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 4970217 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 18599873 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 4970217 | 0.004 |
41 | 27362937 | 0.003 |
16 | 15400505 | 0.002 |
12 | 54600000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 18599873 | 22 |
0.006 | 13884684 | 16 |
0.007 | 3100000 | 2 |
0.008 | 8542434 | 6 |
0.009 | 2327672 | 4 |
Last trade - 10.26am 26/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online